Congress May Let Opioid Billionaires Get Legal Immunity

Legislation to hold the Sacklers accountable stalls as the Chamber of Commerce begins lobbying on the bill.
Congress May Let Opioid Billionaires Get Legal Immunity
A protest outside an August Purdue bankruptcy court hearing. AP Photo/Seth Wenig

Editor’s note: Watch The Daily Poster’s David Sirota’s recent discussion of the Sackler case on The Hill’s “Rising.”

As a coalition of lawmakers tries to hold the billionaire Sackler family accountable for its role in the opioid crisis, Washington’s most powerful business lobby group has now jumped into the intensifying battle over whether courts can grant sweeping legal immunity to those accused of corporate crime.

At issue is a feature of bankruptcy law known as a non-debtor release, which the Sackler family — owners of opioid maker Purdue Pharma — is trying to use to shield its entire corporate empire from current and future litigation. Facing a barrage of lawsuits over its role in the opioid epidemic, Connecticut-based Purdue declared bankruptcy in a New York court known for being friendly to corporate litigants.

Click here to read the full Daily Poster article in Newsweek...


Comments

Only paid subscribers can comment.
Please subscribe or sign in to join the conversation.